Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-01-13 4:14 pm Sale | 2022-12-31 | 13G | Health Catalyst, Inc. HCAT | Millennium Management LLC | 1,797,874 3.300% | -1,032,914 (-36.49%) | Filing History |
| 2022-11-03 4:18 pm Purchase | 2022-11-02 | 13G | Health Catalyst, Inc. HCAT | Point72 Asset Management, L.P. | 2,784,884 5.100% | 2,784,884 (New Position) | Filing History |
| 2022-08-30 4:04 pm Purchase | 2022-08-22 | 13G | Health Catalyst, Inc. HCAT | Millennium Management LLC | 2,830,788 5.200% | 2,830,788 (New Position) | Filing History |
| 2022-08-10 09:34 am Purchase | 2022-07-29 | 13G | Health Catalyst, Inc. HCAT | The Vanguard Group | 5,492,511 10.140% | 1,209,772 (+28.25%) | Filing History |
| 2022-06-10 11:04 am Sale | 2022-06-09 | 13G | Health Catalyst, Inc. HCAT | FMR LLC | 194,897 0.358% | -2,917,127 (-93.74%) | Filing History |
| 2022-04-11 09:01 am Sale | 2022-04-08 | 13G | Health Catalyst, Inc. HCAT | FMR LLC | 3,112,024 5.815% | -4,373,386 (-58.43%) | Filing History |
| 2022-02-14 4:31 pm Purchase | 2022-02-14 | 13G | Health Catalyst, Inc. HCAT | AllianceBernstein L.P. | 3,085,813 6.000% | 3,085,813 (New Position) | Filing History |
| 2022-02-11 12:22 pm Purchase | 2022-02-14 | 13G | Health Catalyst, Inc. HCAT | Capital Research Global Investors | 3,392,000 6.500% | 509,300 (+17.67%) | Filing History |
| 2022-02-10 08:16 am Purchase | 2021-12-31 | 13G | Health Catalyst, Inc. HCAT | The Vanguard Group | 4,282,739 8.230% | 1,398,107 (+48.47%) | Filing History |
| 2022-02-09 09:19 am Purchase | 2022-02-08 | 13G | Health Catalyst, Inc. HCAT | FMR LLC | 7,485,410 14.363% | 2,602,358 (+53.29%) | Filing History |
| 2022-02-04 09:17 am Purchase | 2021-12-31 | 13G | Health Catalyst, Inc. HCAT | Wellington Management Group LLP | 3,622,171 6.960% | 656,268 (+22.13%) | Filing History |
| 2022-02-03 4:41 pm Purchase | 2021-12-31 | 13G | Health Catalyst, Inc. HCAT | BlackRock Inc. BLK | 4,699,392 9.000% | 179,736 (+3.98%) | Filing History |
| 2021-07-12 08:29 am Purchase | 2021-06-30 | 13G | Health Catalyst, Inc. HCAT | BlackRock Inc. BLK | 4,519,656 10.200% | 1,988,256 (+78.54%) | Filing History |
| 2021-04-12 1:05 pm Purchase | 2021-04-09 | 13G | Health Catalyst, Inc. HCAT | FMR LLC | 4,883,052 11.072% | 2,682,743 (+121.93%) | Filing History |
| 2021-02-16 3:11 pm Purchase | 2021-02-16 | 13G | Health Catalyst, Inc. HCAT | Capital Research Global Investors | 2,882,700 6.800% | 2,882,700 (New Position) | Filing History |
| 2021-02-12 8:50 pm Unchanged | 2020-12-31 | 13G | Health Catalyst, Inc. HCAT | SC US (TTGP), LTD. ("SC US (TTGP)") | 0 0.000% | 0 (Unchanged) | Filing History |
| 2021-02-12 5:06 pm Sale | 2020-12-31 | 13G | Health Catalyst, Inc. HCAT | NORWEST VENTURE PARTNERS XI LP | 0 0.000% | -5,904,181 (Position Closed) | Filing History |
| 2021-02-10 10:57 am Purchase | 2020-12-31 | 13G | Health Catalyst, Inc. HCAT | The Vanguard Group | 2,884,632 6.790% | 2,884,632 (New Position) | Filing History |
| 2021-02-08 10:23 am Purchase | 2021-02-05 | 13G | Health Catalyst, Inc. HCAT | FMR LLC | 2,200,309 5.165% | 8,490 (+0.39%) | Filing History |
| 2021-02-04 09:37 am Purchase | 2020-12-31 | 13G | Health Catalyst, Inc. HCAT | Wellington Management Group LLP | 2,965,903 6.980% | 2,965,903 (New Position) | Filing History |